Atenolol in hypertension: is it a wise choice? |
Bo Carlberg, Ola Samuelsson, Lars Hjalmar Lindholm
Source - Lancet 2004; 364: 1684-89
Department of Public Health and Clinical Medicine, Umeå University Hospital, SE 901 85 Umeå, Sweden (B Carlberg MD, Prof L H Lindholm MD); and Department of Nephrology, Sahlgrenska University Hospital, Göteborg, Sweden (O Samuelsson MD)
Correspondence to: Prof Lars H Lindholm LarsHLindholm@fammed. umu.se
Summary |
Comments
your voice counts
There are currently no comments on this post.
Your voice counts
We welcome your comments and are very interested in your point of view, but we ask that you keep them relevant to the article, that they be civil and without commercial links. All comments are moderated prior to being published. We reserve the right to edit or not publish comments that we consider abusive or offensive.
There is extra content here from a third party provider. You will be unable to see this content unless you agree to allow Content Cookies. Cookie Preferences